World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
8356
World Ranking
4162
National Ranking
1900

Josephine H. Cox publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Josephine H. Cox sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 132 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Josephine H. Cox D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Josephine H. Cox sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Josephine H. Cox is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily focuses on the field of Medicine, with specific attention to Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Dermatology, and Genetics.

The scientist has contributed extensively to topics related to mosquito-borne diseases and control, viral infections and outbreaks research, viral infections and vectors, SARS-CoV-2 and COVID-19 research, influenza virus research studies, respiratory viral infections research, and malaria research and control.

Frequent publication venues for Josephine H. Cox include:

  • Journal of Cutaneous Medicine and Surgery
  • The Lancet Infectious Diseases
  • Nature Medicine
  • JAMA
  • The Lancet

Notable recent papers authored or co-authored by Josephine H. Cox are:

  • Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial, 2022, Nature Medicine
  • Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes, 2020, JAMA
  • Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial, 2023, The Lancet
  • Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial, 2022, The Lancet Infectious Diseases
  • Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial, 2023, The Lancet Infectious Diseases

Josephine H. Cox frequently collaborates with several researchers, including:

  • Julie E. Ledgerwood
  • Ingelise J. Gordon
  • Emily E. Coates
  • John R. Mascola
  • Sandra Vazquez

Best Publications

  • A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

    Jeffrey R Currier;Ellen G Kuta;Ellen Turk;Lyndsay B Earhart

  • CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway

    Ulrich Schubert;Luis C. Antón;Igor Bačík;Josephine H. Cox

  • Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    Martin R Gaudinski;Katherine V Houser;Kaitlyn M Morabito;Zonghui Hu

  • Standardization of cytokine flow cytometry assays

    Holden T Maecker;Aline Rinfret;Patricia D'Souza;Janice Darden

  • In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.

    Sandhya Vasan;Arlene Hurley;Arlene Hurley;Sarah J. Schlesinger;Sarah J. Schlesinger;Drew Hannaman

  • Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

    Enoch Muyanja;Aloysius Ssemaganda;Pearline Ngauv;Rafael Cubas

  • Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

    Nicola Borthwick;Tina Ahmed;Beatrice Ondondo;Peter Hayes

  • CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

    Christof Geldmacher;Jeffrey R. Currier;Eva Herrmann;Antelmo Haule

  • Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.

    Josephine H. Cox;Jonathan W. Yewdell;Laurence C. Eisenlohr;Philip R. Johnson

  • TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide.

    I Bacik;J H Cox;R Anderson;J W Yewdell

  • Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

    Alba Grifoni;John Pham;John Sidney;Patrick H O'Rourke

  • Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

    Unknown

  • Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara

    Eric Sandström;Charlotta Nilsson;Bo Hejdeman;Andreas Bråve

  • Nuclear Localization of a Double-Stranded RNA-Binding Protein Encoded by the Vaccinia Virus E3L Gene

    Hao Yuwen;Josephine H. Cox;Jonathan W. Yewdell;Jack R. Bennink

  • Measurement of cytokine release at the single cell level using the ELISPOT assay

    Josephine H Cox;Guido Ferrari;Sylvia Janetzki

  • Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation.

    J H Cox;J R Bennink;J W Yewdell

  • A Phase 1/2 Study of a Multiclade HIV-1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV-Uninfected East Africans (RV 172)

    Hannah Kibuuka;Robert Kimutai;Leonard Maboko;Fred Sawe

  • Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand

    Chitraporn Karnasuta;Robert M. Paris;Josephine H. Cox;Sorachai Nitayaphan

  • Orientation of epitopes influences the immunogenicity of synthetic peptide dimmers

    Josephine H. Cox;Josephine H. Cox;Juraj Ivanyi;Douglas B. Young;Jonathan R. Lamb

  • Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.

    Frances H Priddy;David J M Lewis;Huub C Gelderblom;Hana Hassanin

  • Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.

    Walter Jaoko;Etienne Karita;Kayitesi Kayitenkore;Gloria Omosa-Manyonyi

  • Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.

    Martin R Gaudinski;Emily E Coates;Laura Novik;Alicia Widge

Frequent Co-Authors

Deborah L. Birx
Deborah L. Birx Centers for Disease Control and Prevention
Jill Gilmour
Jill Gilmour Imperial College London
Guido Ferrari
Guido Ferrari Duke University
Patricia E. Fast
Patricia E. Fast International AIDS Vaccine Initiative
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Bernard Moss
Bernard Moss National Institutes of Health
Victoria R. Polonis
Victoria R. Polonis Walter Reed Army Institute of Research
Francine E. McCutchan
Francine E. McCutchan Columbia University
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology and looking to expand their expertise in healthcare, exploring related online degrees can open exciting career pathways. Many professionals transition into nursing roles to gain a broader clinical perspective, with options like the accelerated nurse practitioner program allowing for faster advancement in patient care and leadership.

Non-nurses aiming to enter healthcare fields can benefit from flexible and supportive options such as online nursing programs for non nurses. These programs provide foundational training while accommodating diverse backgrounds.

Accelerated pathways remain a popular choice for non-nurses, with accelerated BSN programs for non nurses offering an efficient route to earn a Bachelor of Science in Nursing. Such programs help fast-track entry into nursing careers connected to immunology research and practice.

For those beginning their healthcare journey, easy LPN programs to get into provide accessible nursing credentials that can serve as stepping stones toward specialized roles involving immunology. These options make healthcare education attainable and diverse.

Best Scientists Citing Josephine H. Cox

Trending Scientists

Recently Published Articles